drugset / Trial / NCT01623466

Study to Evaluate Pharmacokinetics Profile, Wearability, and Safety of 2 Progestin-Only Patches

NCT01623466

Phase 1/2 Completed 36 enrolled Agile Therapeutics
RandomizedParallel-groupOpen-labelTreatment

Summary

Pharmacokinetics, safety and wearability in two size patches of AG890 over eight weeks will be evaluated.

Timeline

Start
2012-07
Primary completion
2012-09
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Levonorgestrel Small molecule 6.5 unknown Other
Subject Levonorgestrel Small molecule 12.5 unknown Other

Indications

No indication recorded.